I-Tybost (i-cobicistat) - Ulwazi lwe-HIV lweDrug

Ukuhlukaniswa:

I-Tybost (cobicistat) yisidakamizwa esichazwa njenge-CYP3A inhibitor esetshenziselwa ukwelashwa kwe- HIV . U-Tybost usebenza "ngokukhulisa" ukuhlushwa kwe-plasma yemithi elwa nezidambisigciwane, i-Vitekta (elvitegravir), i- Reyataz (atazanavir) ne- Prezista (i-darunavir) , uma isetshenziselwa ukwelashwa kwama-antiretroviral (ipati) .

I-Tybost iyingxenye yezinhlanganisela ezintathu ezilinganiselwe izidakamizwa, i- Stribild (elvitegravir + cobicistat + tenofovir + emtricitabine) , u- Evotaz (atanazavir + cobicistat) no- Prezcobix (i-darunavir + cobicistat) ,

U-Tybost wamukelwa yi-US Food and Drug Administration (FDA) ngoSepthemba 2014 kubo bonke abagulayo abadala nabasanda kutholwa abane-HIV-1.

Ifomu:

I-tablet ye-150mg ehlanganiswe ngefilimu, i-orange ekhanyayo embala futhi ibhalwe ngezinhlamvu "GSI" ngakolunye uhlangothi.

Isilinganiso:

Ithebulethi eyodwa ka-150mg ethathwa nsuku zonke ngokudla ngesikhathi esisodwa njengoReyataz noma i-Prezista. Ukwelashwa kufanele kufake enye noma ngaphezulu, ehambisana nemithi noma izidambisigciwane.

Imiyalo:

Ngaphambi kokuqala, iziguli kufanele zihlolwe ukuze zihlolwe imvume yokuqalwa kwe-creatinine njengoba u-Tybost angase akwazi ukulimaza umsebenzi wezinso (izinso), kaningi ezigulini ezinezifo ezingasebenzi ezingaziwa noma ezingaziwa. Uma uqondiswa nge- Viread (i-tenofovir) -isidakamizwa futhi saziwa ngokubangela ukukhubazeka komonakalo kwezinye-kunconywa ukuthi iziguli zihlolwe ukuvunyelwa kwe-creinine esilinganiselwe, i-urine glucose kanye namaprotheni omchamo.

Imiphumela emibi evamile:

Esifundweni sesifundo se-Phase III somuntu, kunezibalo eziningana zezidakamizwa ezingase zibonwe uma usebenzisa i-Tybost.

Izenzakalo ezivame kakhulu, ezibikwe ku-2% noma ngaphansi kweziguli, zaziyizi:

Imiphumela emibi engavamile ihlanganisa ukukhathala, ikhanda, ukulala, ukuhlanza kanye nobuhlungu obuphezulu besisu. Amatshe asezinso nawo ahlonishwe kwezinye iziguli lapho u-Tybost eqondiswa khona noReyataz noViread, nakuba amacala ayebhekwa njengobumnene futhi awazange akhiphe ukwelashwa.

Ukuphikisana kwezidakamizwa:

U-Tybost akufanele athathwe ngezidakamizwa ezilandelayo noma izithako ze-herbal:

Ukusebenzisana kwezidambisigciwane:

Ukusetshenziswa kukaTybost ngokulandela izidakamizwa ze-antiretroviral kungaholela ekulahlekelweni komphumela wokwelashwa kwesidakamizwa esihambisana nalokhu noma ukwanda kwemiphumela emibi:

Okunye ukusebenzisana noma ukucabangela:

Imithombo:

I-Sciences yaseGileyadi. "U-Tybost (cobicistat) - ULWAZI LOKUPHILA OKUQHELEKILE." Foster City, California; ifinyelelwe ngoFebhuwari 3, 2015.